MRRC.F Stock Overview
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Wayland Group Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -90.00% |
| 3 Year Change | -99.99% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MRRC.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | -90.0% | 10.6% | 21.9% |
Return vs Industry: MRRC.F underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: MRRC.F underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| MRRC.F volatility | |
|---|---|
| MRRC.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRRC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MRRC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | n/a | www.waylandgroup.com |
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada.
Wayland Group Corp. Fundamentals Summary
| MRRC.F fundamental statistics | |
|---|---|
| Market cap | US$237.00 |
| Earnings (TTM) | -US$31.37m |
| Revenue (TTM) | US$1.96m |
0.0x
P/S Ratio0.0x
P/E RatioIs MRRC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRRC.F income statement (TTM) | |
|---|---|
| Revenue | CA$2.68m |
| Cost of Revenue | CA$4.80m |
| Gross Profit | -CA$2.12m |
| Other Expenses | CA$40.84m |
| Earnings | -CA$42.96m |
Last Reported Earnings
Sep 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MRRC.F perform over the long term?
See historical performance and comparison